Author:
Asakura Maiko,Ikegame Kazuhiro,Yoshihara Satoshi,Taniguchi Shuichi,Mori Takehiko,Etoh Tetsuya,Takami Akiyoshi,Yoshida Takashi,Fukuda Takahiro,Hatanaka Kazuo,Kanamori Heiwa,Yujiri Toshiaki,Atsuta Yoshiko,Sakamaki Hisashi,Suzuki Ritsuro,Ogawa Hiroyasu
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Stocchi R, Ward KN, Fanin R, Baccarani M, Apperley JF. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation. Haematologica. 1999;84:71–9.
2. Boeckh M. Current antiviral strategies for controlling cytomegalovirus in chematopoietic stem cell transplant recipients: prevention and therapy. Transpl Infect Dis. 1999;1:165–78.
3. Boeckh M, Nichols WG, Papanicolaou G, Rubin R, Wingard JR, Zaia J. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies. Biol Blood Marrow Transplant. 2003;9:543–58.
4. Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y. Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003;32:801–7.
5. Biron K. Antiviral drugs for cytomegalovirus disease. Antiviral Res. 2006;71:154–63.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献